Benlysta 120 mg powder for concentrate for solution for infusion

Active Ingredient
Dosage Form
Powder for Solution for infusion
Legal Category
A - prescription, may not be renewed
Date of revision
10/2026

*further information is available on request to the holder of the authorisation or in the SPC

SPC section shown.

Loading the document

GlaxoSmithKline (Ireland) Ltd

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland, D24 Dublin

Telephone
+3531800244255